Evidence map›Paper›PMID 37350824›Full record

ArticleChemical science2023

Replacing the BO in BODIPY: unlocking the path to SBDIPY and BIDIPY chromophores.

André Korzun, Stefano Crespi, Christopher Golz, Alessandro Bismuto

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Beyond BODIPY: dipyrrin complexes of P-block elements.Journal of coordination chemistry · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

André KorzunInstitut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen Tammannstr. 2 37077 Göttingen Germany alessandro.bismuto@chemie.uni-goettingen.de.
Stefano CrespiDepartment of Chemistry - Ångström Laboratory Uppsala University Box 523, 751 20 Uppsala Sweden.ORCID https://orcid.org/0000-0002-0279-4903
Christopher GolzInstitut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen Tammannstr. 2 37077 Göttingen Germany alessandro.bismuto@chemie.uni-goettingen.de.
Alessandro BismutoInstitut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen Tammannstr. 2 37077 Göttingen Germany alessandro.bismuto@chemie.uni-goettingen.de.ORCID https://orcid.org/0000-0002-5840-1144
University of Göttingen · DEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boron-based dipyrrin chromophores (BODIPY) have found widespread application over the last twenty years in fields as diverse as medicine and materials. Thus, several efforts have been placed to exchange boron with other elements, with the aim of developing materials with complementary luminescent properties. However, despite these attempts, the incorporation of other main-group elements in dipyrrin scaffolds remains still rare. We have successfully synthesized and characterized novel chromophores based on antimony and bismuth, SBDIPY and BIDIPY. Solution stabilities have been investigated by VT-UV/vis spectroscopy and the fluorescence emission studied and supported by computational analysis. We were also able to isolate the first direct analogue of BODIPY containing fluoride handles, disclosing preliminary luminescent features.

Identifiers

PMID37350824
PMCPMC10284139
OpenAlexW4379799210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.